Compare AVDL & LU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AVDL | LU |
|---|---|---|
| Founded | 2015 | 2005 |
| Country | Ireland | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.3B |
| IPO Year | 1996 | 2020 |
| Metric | AVDL | LU |
|---|---|---|
| Price | $21.69 | $2.91 |
| Analyst Decision | Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $19.14 | N/A |
| AVG Volume (30 Days) | ★ 1.6M | 1.2M |
| Earning Date | 03-02-2026 | 03-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $248,517,000.00 | ★ $4,671,260,668.00 |
| Revenue This Year | $65.47 | N/A |
| Revenue Next Year | $30.88 | $1.62 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 79.88 | N/A |
| 52 Week Low | $6.38 | $2.30 |
| 52 Week High | $23.57 | $4.57 |
| Indicator | AVDL | LU |
|---|---|---|
| Relative Strength Index (RSI) | 63.88 | 52.82 |
| Support Level | $21.52 | $2.49 |
| Resistance Level | $21.69 | $2.73 |
| Average True Range (ATR) | 0.06 | 0.08 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 66.67 | 73.58 |
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.
Lufax Holding Ltd is a technology-empowered personal financial services platform in China. The company address the large unmet demand for personal lending among small business owners as well as salaried workers in China and provides tailor-made wealth management solutions to China's middle class and affluent population. Its platform has two hubs namely Retail Credit Facilitation Hub and Wealth Management Hub.